XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 209,188 $ 216,454
Accounts receivable 46,665 40,378
Supplies and inventory 18,328 16,128
Prepaid expenses and other current assets 16,237 12,661
Total current assets 290,418 285,621
Property, plant and equipment, net 21,566 20,584
Right-of-use assets, operating leases 11,167 10,277
Intangible assets, net 116,348 88,593
Goodwill 753,853 702,984
Restricted cash 1,082 876
Other assets 5,639 5,971
Total assets 1,200,073 1,114,906
Current liabilities:    
Accounts payable 12,152 12,943
Accrued liabilities 30,293 38,427
Current portion of deferred revenue 2,602 2,008
Current portion of acquisition-related contingent consideration 6,934 2,657
Current portion of operating lease liabilities 5,982 5,105
Current portion of other liabilities 89 101
Total current liabilities 58,052 61,241
Deferred tax liabilities 1,340 734
Acquisition-related contingent consideration, net of current portion 13,446 518
Operating lease liabilities, net of current portion 8,058 7,525
Other liabilities 528 786
Total liabilities 81,424 70,804
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of March 31, 2024 and December 31, 2023 0 0
Common stock, $0.001 par value; 125,000,000 shares authorized, 76,425,272 and 73,264,738 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 76 73
Additional paid-in capital 1,617,465 1,536,168
Accumulated deficit (469,985) (468,121)
Accumulated other comprehensive loss (28,907) (24,018)
Total stockholders’ equity 1,118,649 1,044,102
Total liabilities and stockholders’ equity $ 1,200,073 $ 1,114,906